Results 281 to 290 of about 42,233 (316)
Some of the next articles are maybe not open access.
Distribution of CGRP and CGRP receptor components in the rat brain
Cephalalgia, 2017Background Calcitonin gene-related peptide and its receptor, consisting of receptor activity-modifying protein 1 and calcitonin receptor-like receptor, are of considerable interest because of the role they play in migraine and recently developed migraine therapies.
Karin Warfvinge +2 more
openaire +4 more sources
The activation of the CGRP receptor
Biochemical Society Transactions, 2013The CGRP (calcitonin gene-related peptide) receptor is a family B GPCR (G-protein-coupled receptor). It consists of a GPCR, CLR (calcitonin receptor-like receptor) and an accessory protein, RAMP1 (receptor activity modifying protein 1). RAMP1 is needed for CGRP binding and also cell-surface expression of CLR.
Barwell, James +6 more
openaire +4 more sources
CGRP receptors: beyond the CGRP1–CGRP2 subdivision?
Trends in Pharmacological Sciences, 2001In a recent TiPS article 1xThe molecular pharmacology of CGRP and related peptide receptor subtypes. Juaneda, C. et al. Trends Pharmacol. Sci. 2000; 21: 432–438Abstract | Full Text | Full Text PDF | PubMed | Scopus (131)See all References1, Juaneda and colleagues reviewed the molecular pharmacology of calcitonin gene-related peptide (CGRP) and related ...
David R. Poyner, Ian W. Marshall
openaire +3 more sources
2018
Calcitonin gene-related peptide (CGRP) was discovered over about 35 years ago through molecular biological techniques. Its activity as a vasodilator and the proposal that it was involved in pain processing were then soon established. Today, we are in the interesting situation of having the approval for the clinical use of antagonists and antibodies ...
Arkless, Kate +2 more
openaire +4 more sources
Calcitonin gene-related peptide (CGRP) was discovered over about 35 years ago through molecular biological techniques. Its activity as a vasodilator and the proposal that it was involved in pain processing were then soon established. Today, we are in the interesting situation of having the approval for the clinical use of antagonists and antibodies ...
Arkless, Kate +2 more
openaire +4 more sources
Serotonin, NO, and CGRP and Headache
Headache: The Journal of Head and Face Pain, 2011Objective.-Identification of the neural mechanisms underlying medication overuse headache resulting from triptans. Methods.-Triptans were administered systemically to rats by repeated intermittent injections or by continuous infusion over 6 days. Periorbital and hind paw sensory thresholds were measured to detect cutaneous allodynia.
MaassenVanDenBrink, A., Ferrari, M.D.
openaire +4 more sources
2012
Receptor activity modifying protein 1 (RAMP1) forms a complex with calcitonin receptor-like receptor (CLR) to produce the receptor for calcitonin gene-related peptide (CGRP). RAMP1 has two main roles. It facilitates the cell-surface expression of CLR. It is also essential for the binding of CGRP to the receptor.
Denise Wootten +4 more
openaire +3 more sources
Receptor activity modifying protein 1 (RAMP1) forms a complex with calcitonin receptor-like receptor (CLR) to produce the receptor for calcitonin gene-related peptide (CGRP). RAMP1 has two main roles. It facilitates the cell-surface expression of CLR. It is also essential for the binding of CGRP to the receptor.
Denise Wootten +4 more
openaire +3 more sources
CGRP Immunoreactivity in the Mammalian Pancreasa
Annals of the New York Academy of Sciences, 1992not ...
Howard A. Reber +7 more
openaire +4 more sources
Journal of Medicinal Chemistry, 2020
The pivotal role of calcitonin gene-related peptide (CGRP) in migraine pathophysiology was identified over 30 years ago, but the successful clinical development of targeted therapies has only recently been realized.
G. Dubowchik +2 more
semanticscholar +1 more source
The pivotal role of calcitonin gene-related peptide (CGRP) in migraine pathophysiology was identified over 30 years ago, but the successful clinical development of targeted therapies has only recently been realized.
G. Dubowchik +2 more
semanticscholar +1 more source
CGRP antagonist activity of short fragments of human αCGRP, CGRP(23–37) and CGRP(19–37)
Peptides, 1992The activity of short C-terminal fragments of human alpha calcitonin gene-related peptide (CGRP), CGRP(19-37), and CGRP(23-37), and of the N-terminally acetylated (Ac) derivative, AcCGRP(19-37), has been investigated in the guinea pig isolated left atria (electrically driven) for their ability to antagonize the positive inotropic effect of human alpha ...
ROVERO, PAOLO, S. Giuliani, C. A. Maggi
openaire +2 more sources
Molecular studies of CGRP and the CGRP family of peptides in the central nervous system
Cephalalgia, 2018BackgroundCalcitonin gene-related peptide is an important target for migraine and other painful neurovascular conditions. Understanding the normal biological functions of calcitonin gene-related peptide is critical to understand the mechanisms of calcitonin gene-related peptide-blocking therapies as well as engineering improvements to these medications.
Erica R Hendrikse +3 more
openaire +3 more sources

